← Leaderboards
Max Eldon Mertens
Harvard Medical School
$101,536
Attributed
$101,536
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $36.8K · FY2017–19$50K$37.5K$25K$12.5K$0
'17
'18
'19
Funding mix
By agency
NIH$101,536 · 1
By mechanism
F31$101,536 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- David M Knipe$35,817,264
- Michaela Ulrike Gack$22,395,027
- Jean M Pesola$2,348,130
- Priscilla Li-Ning Yang$20,185,658
- Danesh Moazed$12,710,271
Others in their field
Other Emerging Leaders on “Infection”
- Chanza Baytop · Westat, Inc.$271,217,917
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$207,651,224
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$73,602,469
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$71,912,072
Research focus
InfectionBaseAntiviral AgentsCellsChromatinChromosome MappingCell NucleusAntiviral ResponseEndoplasmic ReticulumEnv Gene ProductsEpigenetic ProcessFibroblastsFutureGene ActivationGene ExpressionComplexDepositionGenetic TranscriptionHerpes Simplex InfectionsHerpesvirus 1HeterochromatinHistonesImmuneInterest
Grant awards (3)
The Role of the Nuclear Envelope in Antiviral Signaling and HSV-1 Restriction$32,596
F31 · FY2019 · AI · contact PI
The Role of the Nuclear Envelope in Antiviral Signaling and HSV-1 Restriction$32,104
F31 · FY2018 · AI · contact PI
The Role of the Nuclear Envelope in Antiviral Signaling and HSV-1 Restriction$36,836
F31 · FY2017 · AI · contact PI